50242-0077
Herceptin Hylecta
Trastuzumab and Hyaluronidase-oysk
INJECTION, SOLUTION
Subcutaneous
HYALURONIDASE
10000.0
U/5mL

HYALURONIDASE (HUMAN RECOMBINANT)
10000.0
U/5mL

TRASTUZUMAB
600.0
mg/5mL
50242-0077-01
1 VIAL, SINGLE-DOSE in 1 CARTON (50242-077-01) > 6 mL in 1 VIAL, SINGLE-DOSE
Feb. 28, 2019
Immunotherapy
Monoclonal Antibody
HER2
 
In Use